4//SEC Filing
Violette Shelia M. 4
Accession 0000950170-24-115146
CIK 0001661998other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 8:39 PM ET
Size
13.4 KB
Accession
0000950170-24-115146
Insider Transaction Report
Form 4
Q32 Bio Inc.QTTB
Violette Shelia M.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2024-10-11$3.12/sh+4,574$14,271→ 17,874 total - Exercise/Conversion
Common Stock
2024-10-15$7.29/sh+6,000$43,740→ 23,874 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-11−4,361→ 0 totalExercise: $3.12Exp: 2028-12-06→ Common Stock (4,361 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-15−6,000→ 32,891 totalExercise: $7.29Exp: 2030-12-01→ Common Stock (6,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-11−213→ 0 totalExercise: $3.12Exp: 2028-12-06→ Common Stock (213 underlying)
Holdings
- 36,277(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]Shares held by Violette Holdings LLC ("Violette Holdings"). The Reporting Person is a manager of Violette Holdings and disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose.
- [F2]The shares underlying this option are fully vested and exercisable as of the date hereof.
- [F3]The shares underlying this option vest and become exercisable in sixteen (16) equal quarterly installments following December 2, 2020, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Q32 Bio Inc.
CIK 0001661998
Entity typeother
Related Parties
1- filerCIK 0002016144
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 8:39 PM ET
- Size
- 13.4 KB